Mosaic Company Reports $257.6 Million Net Loss in Q1
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy MOS?
Source: NASDAQ.COM
- Financial Performance Decline: Mosaic Company reported a net loss of $257.6 million in Q1, compared to a profit of $238.1 million in the same period of 2025, indicating significant financial pressure that is likely to negatively impact stock prices.
- Widening Loss Per Share: The loss per share was $0.81, contrasting with a profit of $0.75 per share last year, reflecting a sharp decline in profitability that may weaken investor confidence.
- Weak Sales Growth: Although net sales reached $2.998 billion in Q1, up from $2.620 billion in 2025, adjusted EBITDA fell from $544 million to $416 million, indicating a decline in earnings quality.
- Guidance Adjustment: Mosaic has withdrawn its phosphate production guidance for 2026 and plans to partially curtail production in Louisiana and Bartow, reflecting the company's cautious approach amid market uncertainties and revised capital expenditure guidance of $1.25 billion.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOS
Wall Street analysts forecast MOS stock price to rise
13 Analyst Rating
6 Buy
7 Hold
0 Sell
Moderate Buy
Current: 22.190
Low
24.00
Averages
32.38
High
43.00
Current: 22.190
Low
24.00
Averages
32.38
High
43.00
About MOS
The Mosaic Company is a producer and marketer of concentrated phosphate and potash crop nutrients. The Company’s segments include Phosphates, Potash and Mosaic Fertilizantes. The Phosphates segment sells phosphate-based crop nutrients and animal feed ingredients throughout North America and internationally. The Potash business segment owns and operates potash mines and production facilities in Canada and the United States, which produces potash-based crop nutrients, animal feed ingredients and industrial products, and is sold both in domestic and international. The Mosaic Fertilizantes Segment produces and sells phosphate- and potash-based crop nutrients, and animal feed ingredients, in Brazil. In addition to phosphate rock mines and chemical plants, this segment consists of sales offices, crop nutrient blending and bagging facilities, port terminals and warehouses in Brazil and Paraguay. This segment also serves as a distribution outlet for its Phosphates and Potash segments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Mosaic Company Releases Q1 2026 Financial Results
- Earnings Release: The Mosaic Company released its Q1 2026 financial results on May 11, 2026, with details available on its investor website, showcasing the company's ongoing impact in the agricultural sector.
- Investor Conference Call: The company will hold a conference call at 11:00 a.m. Eastern Time on the same day to discuss financial results and address investor questions, enhancing interaction and transparency with stakeholders.
- Global Business Overview: Headquartered in Tampa, Florida, Mosaic is a leading producer of potash and phosphate fertilizers, serving farmers in over 40 countries, highlighting its critical role in the global agricultural supply chain.
- Sustainability Commitment: Through the Mosaic Biosciences platform, the company is focused on developing next-generation biological solutions to improve nutrient use efficiency and crop performance, supporting sustainable agricultural systems, reflecting its strategic emphasis on the future of agriculture.
See More
Mosaic Company Lowers Capital Expenditure Guidance
- Capital Expenditure Cut: Mosaic has reduced its 2026 capital expenditure guidance from $1.5 billion to $1.25 billion, reflecting an optimized project portfolio, although this adjustment is not expected to materially impact medium-term operating rates.
- Disappointing Earnings: The company reported adjusted earnings of $0.05 per share, significantly below the consensus estimate of $0.24, while revenue of $3.0 billion narrowly exceeded analysts' expectations of $2.93 billion, indicating volatility in market conditions.
- Production Guidance Withdrawal: Mosaic has withdrawn its phosphate production guidance due to record-high sulfur prices and tight raw material supply, planning to partially curtail production at its Louisiana and Bartow facilities, demonstrating a cautious approach to market dynamics.
- Monitoring Market Dynamics: The company is closely monitoring raw material markets, noting that while agricultural commodity prices have risen since the beginning of the year, disruptions in production and logistics continue to affect phosphate and related raw materials, reflecting a cautious optimism about future market conditions.
See More
Mosaic Company Reports $257.6 Million Net Loss in Q1
- Financial Performance Decline: Mosaic Company reported a net loss of $257.6 million in Q1, compared to a profit of $238.1 million in the same period of 2025, indicating significant financial pressure that is likely to negatively impact stock prices.
- Widening Loss Per Share: The loss per share was $0.81, contrasting with a profit of $0.75 per share last year, reflecting a sharp decline in profitability that may weaken investor confidence.
- Weak Sales Growth: Although net sales reached $2.998 billion in Q1, up from $2.620 billion in 2025, adjusted EBITDA fell from $544 million to $416 million, indicating a decline in earnings quality.
- Guidance Adjustment: Mosaic has withdrawn its phosphate production guidance for 2026 and plans to partially curtail production in Louisiana and Bartow, reflecting the company's cautious approach amid market uncertainties and revised capital expenditure guidance of $1.25 billion.
See More
Moderna Vaccine Development Boosts Stock Price
- Moderna Vaccine Progress: Moderna's stock surged nearly 9% after a U.S. citizen tested positive for hantavirus, with the company announcing last week its early-stage development of a vaccine, highlighting its innovative capabilities and market potential in biotechnology.
- Lumentum Joins Nasdaq 100: Lumentum's shares rose nearly 5% as it prepares to replace CoStar in the Nasdaq 100 index on May 18, a move that will enhance its market visibility and attract more investor interest.
- Monday.com Earnings Beat: Monday.com shares soared 26% after reporting a 24% year-over-year revenue increase to $351.3 million in its first-quarter earnings, exceeding analyst expectations of $339.1 million, indicating the successful launch of its AI platform driving business growth.
- Constellation Energy Strong Performance: Constellation Energy's stock rose 1% following its first-quarter revenue of $11.12 billion, significantly surpassing the $8.46 billion expected by analysts, with adjusted earnings per share at $2.74, showcasing the company's robust performance in the clean energy sector.
See More
Trump and Xi Summit Amid Rising Tensions
- Iran Situation Impact: The Trump administration is striving to resolve the Iran issue before the summit with Xi Jinping on May 14-15, with investors hoping for the reopening of the Strait of Hormuz; failure to reach an agreement could negatively impact the market.
- Inflation Data Expectations: Economists forecast the consumer price index to rise from 3.3% to 3.9%, providing crucial insights into stagflation impacts, with heightened risks if the Strait remains closed, potentially pressuring the economy further.
- Aviation Crisis: An airline CEO noted that the jet fuel crisis could hit airlines harder than Covid, highlighting the profound effects of oil price volatility on the industry, particularly affecting lower-income consumers more severely.
- AI Investment Surge: Despite market challenges, the S&P 500 has reached an all-time high, driven by earnings growth from the Magnificent Seven companies, as retail investors return to focus on AI and semiconductor stocks, reflecting confidence in future growth.
See More
Mosaic Scheduled to Announce Q1 Earnings on May 11
- Earnings Announcement: Mosaic is set to release its Q1 earnings on May 11 before the market opens, with consensus EPS estimates at $0.22, reflecting a 55.1% year-over-year decline, while revenue is expected to reach $2.9 billion, indicating a 10.7% increase, suggesting cautious market sentiment regarding its profitability.
- Historical Performance Review: Over the past two years, Mosaic has only beaten EPS estimates 25% of the time and revenue estimates 13% of the time, highlighting volatility in its earnings forecasts and market concerns about its future performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen one upward revision and six downward adjustments, while revenue estimates have experienced four upward revisions and two downward changes, indicating divergent analyst views on Mosaic's future performance, which may affect investor confidence.
- Market Environment Impact: Despite external challenges such as fertilizer supply disruptions driven by Iran, Mosaic is viewed as a contrarian opportunity, particularly against the backdrop of rising fertilizer prices, demonstrating its potential resilience amid market fluctuations.
See More
Mosaic Company Releases Q1 2026 Financial Results
- Earnings Release: The Mosaic Company released its Q1 2026 financial results on May 11, 2026, with details available on its investor website, showcasing the company's ongoing impact in the agricultural sector.
- Investor Conference Call: The company will hold a conference call at 11:00 a.m. Eastern Time on the same day to discuss financial results and address investor questions, enhancing interaction and transparency with stakeholders.
- Global Business Overview: Headquartered in Tampa, Florida, Mosaic is a leading producer of potash and phosphate fertilizers, serving farmers in over 40 countries, highlighting its critical role in the global agricultural supply chain.
- Sustainability Commitment: Through the Mosaic Biosciences platform, the company is focused on developing next-generation biological solutions to improve nutrient use efficiency and crop performance, supporting sustainable agricultural systems, reflecting its strategic emphasis on the future of agriculture.
See More
Mosaic Company Lowers Capital Expenditure Guidance
- Capital Expenditure Cut: Mosaic has reduced its 2026 capital expenditure guidance from $1.5 billion to $1.25 billion, reflecting an optimized project portfolio, although this adjustment is not expected to materially impact medium-term operating rates.
- Disappointing Earnings: The company reported adjusted earnings of $0.05 per share, significantly below the consensus estimate of $0.24, while revenue of $3.0 billion narrowly exceeded analysts' expectations of $2.93 billion, indicating volatility in market conditions.
- Production Guidance Withdrawal: Mosaic has withdrawn its phosphate production guidance due to record-high sulfur prices and tight raw material supply, planning to partially curtail production at its Louisiana and Bartow facilities, demonstrating a cautious approach to market dynamics.
- Monitoring Market Dynamics: The company is closely monitoring raw material markets, noting that while agricultural commodity prices have risen since the beginning of the year, disruptions in production and logistics continue to affect phosphate and related raw materials, reflecting a cautious optimism about future market conditions.
See More
Mosaic Company Reports $257.6 Million Net Loss in Q1
- Financial Performance Decline: Mosaic Company reported a net loss of $257.6 million in Q1, compared to a profit of $238.1 million in the same period of 2025, indicating significant financial pressure that is likely to negatively impact stock prices.
- Widening Loss Per Share: The loss per share was $0.81, contrasting with a profit of $0.75 per share last year, reflecting a sharp decline in profitability that may weaken investor confidence.
- Weak Sales Growth: Although net sales reached $2.998 billion in Q1, up from $2.620 billion in 2025, adjusted EBITDA fell from $544 million to $416 million, indicating a decline in earnings quality.
- Guidance Adjustment: Mosaic has withdrawn its phosphate production guidance for 2026 and plans to partially curtail production in Louisiana and Bartow, reflecting the company's cautious approach amid market uncertainties and revised capital expenditure guidance of $1.25 billion.
See More
Moderna Vaccine Development Boosts Stock Price
- Moderna Vaccine Progress: Moderna's stock surged nearly 9% after a U.S. citizen tested positive for hantavirus, with the company announcing last week its early-stage development of a vaccine, highlighting its innovative capabilities and market potential in biotechnology.
- Lumentum Joins Nasdaq 100: Lumentum's shares rose nearly 5% as it prepares to replace CoStar in the Nasdaq 100 index on May 18, a move that will enhance its market visibility and attract more investor interest.
- Monday.com Earnings Beat: Monday.com shares soared 26% after reporting a 24% year-over-year revenue increase to $351.3 million in its first-quarter earnings, exceeding analyst expectations of $339.1 million, indicating the successful launch of its AI platform driving business growth.
- Constellation Energy Strong Performance: Constellation Energy's stock rose 1% following its first-quarter revenue of $11.12 billion, significantly surpassing the $8.46 billion expected by analysts, with adjusted earnings per share at $2.74, showcasing the company's robust performance in the clean energy sector.
See More
Trump and Xi Summit Amid Rising Tensions
- Iran Situation Impact: The Trump administration is striving to resolve the Iran issue before the summit with Xi Jinping on May 14-15, with investors hoping for the reopening of the Strait of Hormuz; failure to reach an agreement could negatively impact the market.
- Inflation Data Expectations: Economists forecast the consumer price index to rise from 3.3% to 3.9%, providing crucial insights into stagflation impacts, with heightened risks if the Strait remains closed, potentially pressuring the economy further.
- Aviation Crisis: An airline CEO noted that the jet fuel crisis could hit airlines harder than Covid, highlighting the profound effects of oil price volatility on the industry, particularly affecting lower-income consumers more severely.
- AI Investment Surge: Despite market challenges, the S&P 500 has reached an all-time high, driven by earnings growth from the Magnificent Seven companies, as retail investors return to focus on AI and semiconductor stocks, reflecting confidence in future growth.
See More
Mosaic Scheduled to Announce Q1 Earnings on May 11
- Earnings Announcement: Mosaic is set to release its Q1 earnings on May 11 before the market opens, with consensus EPS estimates at $0.22, reflecting a 55.1% year-over-year decline, while revenue is expected to reach $2.9 billion, indicating a 10.7% increase, suggesting cautious market sentiment regarding its profitability.
- Historical Performance Review: Over the past two years, Mosaic has only beaten EPS estimates 25% of the time and revenue estimates 13% of the time, highlighting volatility in its earnings forecasts and market concerns about its future performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen one upward revision and six downward adjustments, while revenue estimates have experienced four upward revisions and two downward changes, indicating divergent analyst views on Mosaic's future performance, which may affect investor confidence.
- Market Environment Impact: Despite external challenges such as fertilizer supply disruptions driven by Iran, Mosaic is viewed as a contrarian opportunity, particularly against the backdrop of rising fertilizer prices, demonstrating its potential resilience amid market fluctuations.
See More
